Pulmatrix Correlations

PULM Stock

USD 6.11 0.03 0.49%

The current 90-days correlation between Pulmatrix and Akari Therapeutics PLC is 0.02 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pulmatrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pulmatrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Pulmatrix Correlation With Market

Good diversification

The correlation between Pulmatrix and DJI is -0.14 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

Moving together with Pulmatrix Stock

0.7	DMAC	DiaMedica Therapeutics	Pair Corr
0.85	VCEL	Vericel Corp Ord	Pair Corr
0.83	VCYT	Veracyte Potential Growth	Pair Corr
0.71	DRTS	Alpha Tau Medical	Pair Corr
0.63	DVAX	Dynavax Technologies	Pair Corr
0.86	DYAI	Dyadic International	Pair Corr
0.63	KTTAW	Pasithea Therapeutics	Pair Corr
0.67	VRNA	Verona Pharma PLC	Pair Corr
0.66	VSTM	Verastem	Pair Corr

Moving against Pulmatrix Stock

0.94	DRRX	Durect	Pair Corr
0.91	ME	23Andme Holding	Pair Corr
0.89	VALN	Valneva SE ADR	Pair Corr
0.88	VIGL	Vigil Neuroscience	Pair Corr
0.87	VKTX	Viking Therapeutics	Pair Corr
0.84	DTIL	Precision BioSciences	Pair Corr
0.83	VINC	Vincerx Pharma	Pair Corr
0.81	DNTH	Dianthus Therapeutics	Pair Corr
0.78	DNLI	Denali Therapeutics	Pair Corr
0.69	EQ	Equillium	Pair Corr
0.65	DOMH	Dominari Holdings	Pair Corr
0.51	VIRX	Viracta Therapeutics	Pair Corr
0.46	DRMA	Dermata Therapeutics	Pair Corr
0.88	ELVN	Enliven Therapeutics	Pair Corr
0.85	EDIT	Editas Medicine	Pair Corr
0.84	ENTA	Enanta Pharmaceuticals	Pair Corr
0.84	ENVB	Enveric Biosciences	Pair Corr
0.84	EOLS	Evolus Inc	Pair Corr
0.82	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.82	EDSA	Edesa Biotech	Pair Corr
0.75	VRPX	Virpax Pharmaceuticals	Pair Corr
0.75	VYGR	Voyager Therapeutics	Pair Corr

Related Correlations Analysis

	CAPR	AKTX	DFFN	SLNO	ONTX	CBIO	BPTH	MBRX	BLPH
CAPR		0.8	0.73	0.85	0.23	-0.79	0.14	0.72	0.0	CAPR
AKTX	0.8		0.69	0.72	0.15	-0.61	0.24	0.49	0.0	AKTX
DFFN	0.73	0.69		0.76	0.02	-0.8	-0.14	0.77	0.0	DFFN
SLNO	0.85	0.72	0.76		0.28	-0.83	-0.09	0.78	0.0	SLNO
ONTX	0.23	0.15	0.02	0.28		-0.32	-0.19	0.33	0.0	ONTX
CBIO	-0.79	-0.61	-0.8	-0.83	-0.32		0.19	-0.88	0.0	CBIO
BPTH	0.14	0.24	-0.14	-0.09	-0.19	0.19		-0.4	0.0	BPTH
MBRX	0.72	0.49	0.77	0.78	0.33	-0.88	-0.4		0.0	MBRX
BLPH	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		BLPH
	CAPR	AKTX	DFFN	SLNO	ONTX	CBIO	BPTH	MBRX	BLPH

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SLNO	+ 0.85	CAPR
AKTX	+ 0.8	CAPR
MBRX	+ 0.78	SLNO
MBRX	+ 0.77	DFFN
SLNO	+ 0.76	DFFN
DFFN	+ 0.73	CAPR

High negative correlations

MBRX	- 0.88	CBIO
CBIO	- 0.83	SLNO
CBIO	- 0.8	DFFN
CBIO	- 0.79	CAPR
CBIO	- 0.61	AKTX
MBRX	- 0.4	BPTH

Risk-Adjusted Indicators

There is a big difference between Pulmatrix Stock performing well and Pulmatrix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pulmatrix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CAPR	4.08	(0.40)	0.00	(0.38)	0.00	0.00	9.07	(7.53)	33.27
AKTX	5.39	(0.87)	0.00	1.08	0.00	0.00	10.68	(14.53)	47.27
DFFN	2.40	(0.51)	0.00	1.66	0.00	0.00	4.09	(5.32)	12.34
SLNO	2.04	(0.20)	0.00	(0.15)	0.00	0.00	5.14	(4.99)	19.49
ONTX	4.73	0.85	0.17	(1.23)	4.35	(5.89)	7.69	(8.33)	66.73
CBIO	4.25	0.95	0.14	1.05	4.45	(6.17)	9.76	(8.33)	38.47
BPTH	6.48	0.31	0.05	0.12	6.36	(8.94)	7.69	(11.22)	137.94
MBRX	4.53	(0.20)	0.00	(0.13)	0.00	0.00	9.75	(7.87)	38.18
BLPH	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Pulmatrix Corporate Management

MBA CMA	Interim Officer	Profile
Alexander Klibanov	Founder	Profile
Margaret MD	Chief Officer	Profile
David JD	Advisor	Profile
Aidan Curran	VP Affairs	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC